Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Inmune Bio, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsMar-31-20Dec-31-19Sep-30-19Jun-30-19Mar-31-19Dec-31-18Sep-30-18Jun-30-18
   8-K10-K10-Q10-Q10-Q10-K10-Q10-Q
Revenues  0.02.30.00.00.00.00.00.0
Cost of goods sold  0.00.00.0-2.00.00.00.00.0
Gross profit  0.02.30.02.00.00.00.00.0
            Gross margin   100.0%      
Selling, general and administrative   [+]1.31.51.91.71.80.90.95.9
Research and development  0.80.91.20.30.11.00.70.3
Other operating expenses   2.3 0.4    
EBIT   [+]-2.1-2.3-3.1-0.4-1.9-1.9-1.5-6.2
            EBIT margin   -100.0%      
Interest income  0.00.00.00.0    
Other income (expense), net   [+]    0.0   
Pre-tax income  -2.1-2.3-3.1-0.4-1.9-1.9-1.5-6.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -2.1-2.3-3.1-0.4-1.9-1.9-1.5-6.2
            Net margin   -99.4%      
   
Basic EPS   [+]($0.19)($0.23)($0.28)($0.04)($0.20)($0.22)($0.18)($0.71)
Diluted EPS   [+]($0.19)($0.23)($0.28)($0.04)($0.20)($0.22)($0.18)($0.71)
   
Shares outstanding (basic)   [+]10.710.310.810.29.48.78.78.7
Shares outstanding (diluted)   [+]10.710.310.810.29.48.78.78.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy